![Matthew Greenhawt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 393 470 $ per 2026-08-31
Mr. Matthew Greenhawt was previously employed as a Chief Medical Officer by Aquestive Therapeutics, Inc. and a Chief Medical Officer by Asthma & Allergy Foundation of America.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-09 | 77 000 ( 0,06 % ) | 393 470 $ | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
Asthma & Allergy Foundation of America
 Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Teknisk/Vetenskaplig/F&U Direktör | 2026-01-01 |
| AQUESTIVE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 2 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Asthma & Allergy Foundation of America
Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
